INTRODUCTION
Radiation is widely used for cancer therapy. Surface doses are measured using ionization chambers and silicon diodes, whereas the actual doses inside body can not be estimated precisely . In situ dose measurements are important for therapy planning. Chromosome analysis is a good tool with which to assess the damage induced by radiotherapy. Induced chromosomal damage has been shown to be related to the risk of secondary cancer. Most reports'," on chromosomal aberrations induced by X-ray therapy have dealt with dicentrics, fragments, and rings as indicators of chromosome damage because other types of aberrations , such as translocations and insertions, can not be detected after Giemsa staining . In the late 1980s, a new technique called "chromosome painting" (Fluorescence in situ hybridization (FISH) with whole chromosome specific DNA probes) was developed'-'). Chromosome painting provides the rapid scoring of translocations and insertions and has contributed to automated aberration scoring systems6) . Nakano et al.') showed and web) confirmed in an in vitro X-ray irradiation experiment that reciprocal translocations and insertions involving target chromosomes are easily detectable by chromosome painting.
As a mean of estimating actual damage inside body, we now have used chromosome painting to study the lymphocytes of cancer patients given high doses of therapeutic X-rays. We believe that the ability to assess the biological effects of radiotherapy using lymphocytes of cancer patients should be of clinical use. Patients and their histories of X-ray therapy The X-ray histories of 2 control subjects and 6 cancer patients are shown in Table 1 . Control 2, aged 34, had smoked about 20 cigarettes a day over the past 16 years. Both controls had received a regular chest X-ray examination once a year. Stomach cancer, prostate, lung cancer or hepato-cellular carcinoma, was diagnosed for the patients, aged 44 to 81 years, studied. Most had undergone surgery after which they received fractionated X-ray irradiation 4 times a week at 2.25 Gy per fraction in total doses of 40.5 to 70.08 Gy. Only RD4603 received a first X-ray treatment of 4.83 Gy. Blood was collected just after final exposure, except for RD4609, whose blood was taken one week after final exposure. RD4618 received X-ray therapy widely to his chest, especially to the lymph nodes in order to prevent metastasis after the surgical removal of the left lung. Except for RD4627, whose malignancy had progressed too far for surgery, none of the patients had been given anti-cancer drugs before or during the irradiation period. During the course of radiotherapy he had recurrent tumor growth and was given chemotherapy with mitomycin C (12 mg/day), vindesine (4.5 mg/day), and cisplatin (130 mg/day) for 18 days before the blood sampling.
Lymphocyte culture Peripheral blood was collected into heparinized vacutainers and left at room temperature for 1-2 hours , then the leukocyte layer that separated was centrifuged and the serum removed . The precipitated cells were cultured at 37°C for 50 h in 10 ml RPMI1640 medium (Gibco BRL , Gaithersburg, MD, USA) supplemented with 10% fetal bovine serum (Gibco BRL) containing 0.1 ml phytohemagglutinin (Gibco BRL) . Colcemid (0.5 ug/ml) was added to the culture 6 h before harvest unless otherwise stated. Cells were collected by centrifugation, swollen in 0.075 M KCI, then fixed with 3:1 (V/V) methanol : glacial acetic acid . Chromosome preparations were made by the ordinary air-drying method and stored at -20°C in a sealed plastic bag filled with N2 gas until hybridization.
FISH
The FISH technique has been described in detail previously') . Briefly, the chromosomal DNA on the slides was denatured in 70% formamide at 70°C. A denatured SpectrumOrange-conjugated chromosome specific DNA probe for chromosome 4 (Gibco BRL) was placed on the spreads and the whole hybridized for 24 h at 37°C. The slides then were washed and mounted in an antifade/glycerol solution containing 4' ,6 diamidino-2-phenylindole (DAPI) for counterstaining. The disadvantage of chromosome painting is that chromosome aberrations not involved in painted chromosomes can not be detected. If, however, the hypothesis that breaks occur at random over the entire genome is true, then the frequency of aberrations induced over the entire genome can be estimated from the relative DNA content of the painted chromosome(s)9'. When the painting probe for chromosome 4 is used,
12.05% of all exchanges in males are believed to be detected. Accordingly, the estimated genomic frequency of translocations was calculated by dividing the observed frequency by 0.1205.
Equivalent biological doses were extrapolated from the dose-response relationship (Fig. 3) found in an in vitro irradiation experiment on human lymphocytes" based on the estimated genomic frequency of translocations. 
RESULTS
The chromosomal aberrations detected in approximately 1000 metaphases are shown in Table 2 . One cell with a translocation was observed in each control subject, so there was no difference between the smoker and the non-smoker. The frequency of aberrant cells from the cancer patients ranged from 1.57% to 14.34% and was markedly higher than the frequency in the controls. The frequencies, however, did not depend simply on the total dose. RD4603, who received a high total dose of 70.08 Gy at the prostate, showed a number and type of aberrations similar to those of RD4609 who received a lower total dose of 40.5 Gy at the chest. The lowest frequency of aberrant cells among the 6 patients was found for RD4608, who was exposed to X-rays at the abdomen. Both RD4609 and RD4618 were 76-year-old men , had lung cancer, and received the same total dose of X-rays (40.5 Gy) at the chest, but the frequencies of aberrant cells differed clearly. The blood of the former, however, was sampled 1 week after final exposure , and the latter received X-rays over a wider area. The frequency of aberrant cells was higher in both RD4627 and RD4618 than it was in the other patients. Translocations and dicentrics were the predominant rearrangements among the chromosome aberrations detected. The ratio of translocations to dicentrics was about 1 in RD4598 and RD4608 , whereas it was markedly higher in the other patients. The number of complex aberrations in RD4627 was considerably higher than in the other patients, suggesting that more chromosomal breaks had occurred.
Classification of aberrations Complex
Aberrations involving the interaction of two chromosomes were categorized into five groups (Fig. 1) . The complex aberrations scored, shown in Fig. 2 , were included in the "Events" reported by Tucker et al. 101. Eight of the 16 complex aberrations present in RD4627 were type 1. Lymphocytes from the patients who did not receive chemotherapy showed much fewer complex aberrations than the lymphocytes from RD4627, who did receive it.
Incomplete translocation
Incomplete translocations were categorized into three types (Fig. 4) . Thirty-seven of the 225 translocations were incomplete; 19 were type 1, 4 were type 2, 4 were type 3, and 10 were other types. Type 3 was present only in RD4627. 
DISCUSSION
Only one translocation was seen in the control subjects in our study. Tucker et al.") reported the frequency of chromosome exchanges measured by chromosome painting for 47 healthy adults aged 19 to 77 years. Our present findings are consistent with their data. Andersson12) reported that the mean spontaneous frequency of dicentric chromosomes in human peripheral lymphocytes is 0.08/100 cells. In a chromosome painting analysis using a chromosome 4 probe, about 10550 cells might have to be scored to detect a dicentric of such frequency. As chromosome painting detects translocations that can not be detected after Giemsa staining, it was possible to detect aberrations in a smaller number of cells.
We could not obtain chromosome data for the patients prior to X-ray therapy. Gundy et al.") reported that pre-treatment cancer patients, cancer controls, had 4 times the aberrant cell frequency of healthy controls, evidence of a certain degree of chromosome instability, which may have been a factor in tumor development. In contrast, other investigators'') have reported there is no difference in the frequency of aberrations between cancer controls and healthy controls. A gradual decrease in the frequency of aberrant cells after radiotherapy has been reported' •14) Generally speaking, chromosome aberration frequencies in cancer patients did not show a simple dependence on the total dose (Table 2) . Although RD4609 and RD4618 both received 40.5 Gy, their aberrant cell frequencies differed. The 2.8-fold higher aberration frequency observed in RD4618 may be due to the 2.9-fold larger volume of exposed tissue. We could not explain, however, how the aberration frequencies in RD4603 and RD4608 relate to the total doses and to tissue volume exposed. RD4603 received a higher X ray dose in a larger volume of tissue than did RD4609, but both patients showed similar aberration frequencies and distributions. This may be due to the richer distribution of lymph nodes and blood vessels in the chest , where RD4609 was exposed, than in the area of the prostate, where RD4603 was exposed . In addition, Fong et al. 15) reported that in partial body irradiation the yield of dicentrics from blood samples did not depend on the dose.
The lymphocytes from RD4598 were treated with colcemid for the last 26 h of culture. Consequently, the first metaphases after cell division were accumulated and a high percentage of dicentrics might have been scored. After that, however, because the chromosomes became more condensed and shorter, colcemid treatment was changed to the last 6 h of culture. The frequency of aberrant cells and the number of complex aberrations were highest in RD4627, probably due in part to chemotherapy.
For scoring chromosome aberrations detected by chromosome painting, Savage and Simpson16), and Tucker et al.") have proposed new systems. The results of our study needed to be compared to previous in vitro data in order to estimate the equivalent biological doses ( Table 3 ). The conventional scoring system written in 2.4 Analysis therefore was used.
Certain type of complex type aberrations and incomplete translocations were observed in our study. A complex aberration was formed among at least three chromosomes. It therefore was difficult to understand formation only on the basis of resulting aberrant chromosomes. In the incomplete translocations, type 1 predominated. There are two possibilities for this: 1) Very small, unpainted portions could not be recognized because of the bright painted portion. 2) The centric fragment of chromosome 4 preferably exists alone . Table 3 .
Estimated genomic frequencies of translocations and equivalent biological doses Table 3 shows equivalent biological doses extrapolated from our in vitro study of X-ray-induced translocations$). This table can be used to estimate the intensity of damage induced by radiotherapy. For example, the frequency of translocations observed in the RD4598 lymphocytes was similar to that found for a population of human lymphocytes exposed in vitro to a single dose of about 0.8 Gy (Fig. 3) . The frequency of dicentrics depends markedly on the amount of time cells are cultured and the period of colcemid treatment;
it is not a good index of dose. The equivalent biological dose would be a good parameter to use to express actual damage to lymphocytes which are representative of normal tissue. This estimation would eliminate a factor relating to technique; i.e., the total dose was fractionated in the radiotherapy, whereas a single dose of radiation was used in the in vitro experiment. The estimated genomic frequency of translocation may prove useful as a biomonitoring marker for biological damage caused by exposure to chemicals or radiation.
In conclusion, lymphocytes from cancer patients who received 18-30 X-ray treatments showed 10 to 100-times higher frequency of chromosome aberrations than lymphocytes from healthy controls. The frequency of translocations was higher than the frequencies of dicentrics and rings. Chromosome painting can detect translocations and insertions, aberrations that are undetectable after Giemsa staining. This suggests that chromosome painting can be an effective monitor of chromosomal aberrations in patients given X-ray therapy. Chromosome analysis of lymphocytes circulating throughout the body should provide information for estimating the potential risks (such as secondary cancer) associated with exposure to therapeutic X-rays.
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